Complete your RCR training today!

Exclusive: investigators found plagiarism and data falsification in work from prominent cancer lab

Ohio State University investigations identified misconduct by two scientists in lab of high-profile cancer researcher Carlo Croce. The university has cleared Croce of misconduct, but disciplined him over management problems.

July 20, 2022

Nature

By Richard Van Noorden

"Over the past decade, questions have swirled around the work coming out of a prominent US cancer-research laboratory run by Carlo Croce at the Ohio State University (OSU). Croce, a member of the US National Academy of Sciences, made his name with his work on the role of genes in cancer. But for years, he has faced allegations of plagiarism and falsified images in studies from his group. All told, 11 papers he has co-authored have been retracted, and 21 have required corrections."





The Amyloid Theory: Questions Arise Around Possible Research Misconduct and the Validity of Aß as a Therapeutic Target

After an investigative report published in Science called to question years of research around the existence of an amyloid oligomer known as Aß*56, debates about the amyloid hypothesis have been reignited in the Alzheimer community.

July 29, 2022

NeurologyLive

By Matt Hoffman

"In late July, just days ahead of the Alzheimer’s Association International Conference, the Alzheimer disease (AD) clinical community was lit ablaze with controversy with the publication of a multimonth report from Science bringing to light potentially dubious research practices related to an amyloid-ß (Aß) oligomer that many now claim does not exist, known as Aß*56—the consequences of which could have had downstream effects totaling millions of dollars invested and thousands of hours of research wasted."